MEDICARE PART D

9 Months Ended

Sep. 30, 2023

Insurance [Abstract]

MEDICARE PART D

MEDICARE PART D

We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at September 30, 2023 and December 31, 2022. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.

	September 30, 2023				December 31, 2022
	Risk Corridor Settlement		CMS Subsidies/ Discounts		Risk Corridor Settlement		CMS Subsidies/ Discounts
	(in millions)
Other current assets	$	131	$	517	$	240	$	696
Trade accounts payable and accrued expenses	(150)		(3,566)		(166)		(1,236)
Net current (liability) asset	(19)		(3,049)		74		(540)
Other long-term assets	235		—		19		—
Other long-term liabilities	(123)		—		(78)		—
Net long-term asset (liability)	112		—		(59)		—
Total net asset (liability)	$	93	$	(3,049)	$	15	$	(540)